Why the study?
The human gut microbiota is considered an innovative area of study and a potential new target for the prevention and treatment of cardiovascular diseases.
Gut microbiota dysbiosis is associated with chronic heart failure and its progression, highlighting the microbiome as a potential novel target for cardiovascular disease prevention and treatment.
Answers are grounded in this paper and cite their sources.
Gut microbiota changes may associate with CVD; leaves open microbiome-targeted interventions pending randomized trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Khazova et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: